Biomerica, Inc. (NASDAQ:BMRA) Sees Significant Decrease in Short Interest

Biomerica, Inc. (NASDAQ:BMRAGet Free Report) was the recipient of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 49,700 shares, a decrease of 65.5% from the February 28th total of 143,900 shares. Based on an average daily volume of 7,100,000 shares, the short-interest ratio is presently 0.0 days. Currently, 0.3% of the company’s stock are sold short.

Biomerica Price Performance

Biomerica stock opened at $0.64 on Thursday. Biomerica has a 1-year low of $0.24 and a 1-year high of $1.27. The business has a fifty day moving average price of $0.67 and a 200-day moving average price of $0.45. The stock has a market capitalization of $11.70 million, a price-to-earnings ratio of -1.88 and a beta of -1.16.

Biomerica (NASDAQ:BMRAGet Free Report) last issued its quarterly earnings results on Tuesday, January 14th. The company reported ($0.06) earnings per share for the quarter. Biomerica had a negative return on equity of 90.19% and a negative net margin of 100.52%.

Institutional Trading of Biomerica

A hedge fund recently raised its stake in Biomerica stock. Granahan Investment Management LLC grew its stake in Biomerica, Inc. (NASDAQ:BMRAFree Report) by 24.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 658,767 shares of the company’s stock after buying an additional 131,306 shares during the period. Granahan Investment Management LLC owned 3.59% of Biomerica worth $198,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 22.28% of the company’s stock.

About Biomerica

(Get Free Report)

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.

Featured Articles

Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.